{
  "ptid_time": "007_S_4568_2012-03-01",
  "img_path": "/data/qiuhui/data/adni/images/007_S_4568/2012-03-01/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 43,985 mm³, 56.7% above the reference mean. With a Z-score of 1.30 (90.3th percentile), this represents mild enlargement; hippocampal volume measures 6,166 mm³, 13.3% below the reference mean. With a Z-score of -1.22 (11.1th percentile), this represents mild atrophy; whole brain volume measures 1,060,840 mm³, 8.8% above the reference mean. With a Z-score of 1.11 (86.7th percentile), this represents mild enlargement; entorhinal cortex volume measures 2,833 mm³, 22.9% below the reference mean. With a Z-score of -1.40 (8.0th percentile), this represents mild atrophy; fusiform gyrus volume measures 15,351 mm³, 9.8% below the reference mean. With a Z-score of -0.89 (18.7th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,826 mm³, 19.1% above the reference mean. With a Z-score of 1.66 (95.1th percentile), this represents moderate enlargement. ",
  "text_data": "Age is 70.7 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Smoking; Major Surgical Procedures. MMSE: 23.0. MoCA: 20.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.36 SUVR (significant elevated); Amyloid beta: 590.90 pg/mL (mild reduced); Total tau: 536.30 pg/mL (profound elevated); Phosphorylated tau: 54.70 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild hippocampal and entorhinal cortex atrophy, which are key regions affected in Alzheimer's disease (AD). The CSF biomarkers (elevated T-tau, P-tau, and reduced Aβ) strongly support AD pathology. The cognitive scores (MMSE 23, MoCA 20) indicate mild cognitive impairment.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**  \n\nThe combination of structural atrophy in AD-vulnerable regions, abnormal CSF biomarkers, and cognitive decline strongly suggests dementia due to AD. The APOE4 carrier status further supports this diagnosis.",
  "timestamp": "2025-07-25T22:02:58.747357"
}